New Search

Your search found 215 records, sorted by year and then date of acquisition.

1. Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicentre, Open-Label, Randomised Controlled Trial. doc type doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 The Lancet 2017 (in press). [doi: 10.1016/S0140-6736(17)32812-X].
 
2. A Randomized Placebo-Controlled Trial of N-acetylcysteine for Cannabis Use Disorder in Adults. doc type
  Gray, Kevin M. ; Sonne, Susan C. ; McClure, Erin A. ; Ghitza, Udi E. ; Matthews, Abigail G. ; McRae-Clark, Aimee L. ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Wiest, Katharina ; Mooney, Larissa J. ; Hasson, Albert ; Walsh, Sharon L. ; Lofwall, Michelle R. ; Babalonis, Shanna ; Lindblad, Robert W. ; Sparenborg, Steven ; Wahle, Aimee ; King, Jacqueline S. ; Baker, Nathaniel L. ; Tomko, Rachel L. ; Haynes, Louise F. ; Vandrey, Ryan G. ; Levin, Frances R.
 Drug and Alcohol Dependence 2017;177:249-257. [doi: 10.1016/j.drugalcdep.2017.04.020].
 
3. The Prescription Opioid Addiction Treatment Study: What Have We Learned. doc type
  Weiss, Roger D. ; Rao, Vinod
 Drug and Alcohol Dependence 2017;173:S48-S54. [doi: 10.1016/j.drugalcdep.2016.12.001].
 
4. Volatility and Change in Chronic Pain Severity Predict Outcomes of Treatment for Prescription Opioid Addiction. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Addiction 2017;112(7):1202-1209. [doi: 10.1111/add.13782].
 
5. Feasibility and Safety of Extended-Release Naltrexone Treatment of Opioid and Alcohol Use Disorder in HIV Clinics: A Pilot/Feasibility Randomized Trial. doc type doc type
  Korthuis, P. Todd ; Lum, Paula J. ; Vergara-Rodriguez, Pamela ; Ahamad, Keith ; Wood, Evan ; Kunkel, Lynn E. ; Oden, Neal L. ; Lindblad, Robert ; Sorensen, James L. ; Arenas, Virgilio ; Ha, Doan ; Mandler, Raul N. ; McCarty, Dennis
 Addiction 2017;112(6):1036-1044. [doi: 10.1111/add.13753].
 
6. Quitting Smoking During Substance Use Disorders Treatment: Patient and Treatment-Related Variables. doc type
  Campbell, Barbara K. ; Le, Thao ; Tajima, Barbara M. ; Guydish, Joseph R.
 Journal of Substance Abuse Treatment 2017;73:40-46. [doi: 10.1016/j.jsat.2016.11.002].
 
7. The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. doc type
  Carroll, Kathleen M. ; Weiss, Roger D.
 American Journal of Psychiatry 2017;174(8):738-747. [doi: 10.1176/appi.ajp.2016.16070792].
 
8. A Polymorphism in the OPRM1 3'-Untranslated Region is Associated with Methadone Efficacy in Treatment Opioid Dependence. doc type
  Crist, Richard C. ; Doyle, Glenn A. ; Nelson, Elliot C. ; Degenhardt, Louisa ; Martin, Nicholas G. ; Montgomery, Grant W. ; Saxon, Andrew J. ; Ling, Walter ; Berrettini, Wade H.
 Pharmacogenomics Journal 2016 (in press). [doi: 10.1038/tpj.2016.89].
 
9. CSAT/CTN Webinar: Research and Evaluation of Treatment and Treatment Systems for Pregnant and Parenting Women with Opioid Use Disorder. doc type
  Johnson, Kimberly ; Jones, Hendree ; Goodman, Daisy ; Chapman, Steven ; Frew, Julia
 Webinar presented December 13, 2016.
 
10. CSAT/CTN Webinar: Adolescent/Youth Projects Updates. doc type
  Johnson, Kimberly ; Fishman, Marc ; Levy, Sharon
 Webinar presented November 29, 2016.
 
11. CSAT/CTN Webinar: NIDA CTN Initiatives and Primary Care Opioid Use Disorders Treatment Trial Briefing. doc type
  Johnson, Kimberly ; Tai, Betty ; Bradley, Katharine
 Webinar presented October 19, 2016.
 
12. CTN Webinar: Preparation for Drug Management and Accountability in a CTN Clinical Trial. doc type
  Novo, Patricia ; Jeffries, Beth
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, October 19, 2016.
 
13. Ethical and Clinical Safety Considerations in the Design of an Effectiveness Trial: A Comparison of Buprenorphine Versus Naltrexone Treatment for Opioid Dependence. doc type
  Nunes, Edward V. ; Lee, Joshua D. ; Sisti, Dominic ; Segal, Andrea ; Caplan, Arthur ; Fishman, Marc J. ; Bailey, Genie L. ; Brigham, Gregory S. ; Novo, Patricia ; Farkas, Sarah ; Rotrosen, John
 Contemporary Clinical Trials 2016;51:34-43. [doi: 10.1016/j.cct.2016.09.006].
 
14. The Coupling of Nicotine and Stimulant Craving During Treatment for Stimulant Dependence. doc type
  Magee, Joshua C. ; Winhusen, Theresa M.
 Journal of Consulting and Clinical Psychology 2016;84(3):230-237. [doi: 10.1037/ccp0000054].
 
15. CTN Webinar: Pharmacotherapy Trials for Adolescent Substance Use Disorders: From Concept to Execution. doc type
  Gray, Kevin M.
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, August 10, 2016.
 
16. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale. doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bailey, Genie L. ; Brigham, Gregory S. ; Cohen, Allan J. ; Fishman, Marc J. ; Ling, Walter ; Lindblad, Robert ; Shmueli-Blumberg, Dikla ; Stablein, Don ; May, Jeanine ; Salazar, Dagmar ; Liu, David S. ; Rotrosen, John
 Contemporary Clinical Trials 2016;50:253-264. [doi: 10.1016/j.cct.2016.08.004].
 
17. Changes in Quality of Life in Cocaine-Dependent Participants Provided Treatment with Buprenorphine+Naloxone Combined with Extended Release Naltrexone. doc type
  Shmueli-Blumberg, Dikla ; Carrizales, Fermin A. ; Kazanis, William H. ; Hillhouse, Maureen ; Matthews, Abigail ; Potter, Jennifer Sharpe
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
18. Participant Treatment Assignment Perceptions in the NIDA CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Matthews, Abigail G. ; Hillhouse, Maureen ; Thomas, Christie ; Ling, Walter ; Shmueli-Blumberg, Dikla
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
19. Utilizing a Two-Stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-Daily Bupropion as a Treatment for Methamphetamine Use Disorder. doc type
  Mooney, Larissa J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Ang, Alfonso ; Sharma, Gaurav ; Terry, Garth ; Chang, Linda ; Walker, N. Robrina ; Trivedi, Madhukar H. ; Croteau, David ; Sparenborg, Steven ; Ling, Walter
 Journal of Addiction Medicine 2016;10(4):236-243. [doi: 10.1097/ADM.0000000000000218].
 
20. Buprenorphine-Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Mooney, Larissa J. ; Thomas, Christie ; Ang, Alfonso ; Matthews, Abigail G. ; Hasson, Albert L. ; Annon, Jeffrey J. ; Sparenborg, Steven ; Liu, David S. ; McCormack, Jennifer ; Church, Sarah ; Swafford, William ; Drexler, Karen ; Schuman, Carolyn ; Ross, Stephen ; Wiest, Katharina L. ; Korthuis, P. Todd ; Lawson, William ; Brigham, Gregory S. ; Knox, Patricia C. ; Dawes, Michael ; Rotrosen, John
 Addiction 2016;111(8):1416-1427. [doi: 10.1111/add.13375].
 
21. Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
 Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].
 
22. Examining Longitudinal Stimulant Use and Treatment Attendance as Parallel Outcomes in Two Contingency Management Randomized Clinical Trials. doc type
  McPherson, Sterling ; Brooks, Olivia ; Barbosa-Leiker, Celestina ; Lederhos, Crystal ; Lamp, Amanda ; Murphy, Sean ; Layton, Matthew E. ; Roll, John M.
 Journal of Substance Abuse Treatment 2016;61:18-25. [doi: 10.1016/j.jsat.2015.08.008].
 
23. Evaluating Nicotine Craving, Withdrawal, and Substance Use as Mediators of Smoking Cessation in Cocaine- and Methamphetamine-Dependent Patients. doc type
  Magee, Joshua C. ; Lewis, Daniel F. ; Winhusen, Theresa M.
 Nicotine and Tobacco Research 2016;18(5):1196-1201. [doi: 10.1093/ntr/ntv121].
 
24. Pain Volatility and Prescription Opioid Addiction Treatment Outcomes in Patients With Chronic Pain. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Experimental and Clinical Psychopharmacology 2015;23(6):428-435. [doi: 10.1037/pha0000039].
 
25. The Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth with Opioid Dependence. doc type
  Poole, Sabrina A. ; Pecoraro, Anna ; Subramaniam, Geetha A. ; Woody, George E. ; Vetter, Victoria
 Journal of Addiction Medicine 2016;10(1):26-33. [doi: 10.1097/ADM.0000000000000176].
 
26. An Application of Analyzing the Trajectories of Two Disorders: A Parallel Piecewise Growth Model of Substance Use and Attention-Deficit/Hyperactivity Disorder. doc type
  Mamey, Mary Rose ; Barbosa-Leiker, Celestina ; McPherson, Sterling ; Burns, G. Leonard ; Parks, Craig ; Roll, John M.
 Experimental and Clinical Psychology 2015;23(6):422-427. [doi: 10.1037/pha0000047].
 
27. Treatment Outcomes in Opioid Dependent Patients with Different Buprenorphine/Naloxone Induction Dosing Patterns and Trajectories. doc type
  Jacobs, Petra ; Ang, Alfonso ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Nielsen, Suzanne ; Wakim, Paul G. ; Mai, Barbara E. ; Mooney, Larissa J. ; Potter, Jennifer Sharpe ; Blaine, Jack D.
 American Journal on Addictions 2015;24:667-675. [doi: 10.1111/ajad.12288].
 
28. Anxiety and Depressed Mood Decline Following Smoking Abstinence in Adult Smokers with Attention Deficit Hyperactivity Disorder. doc type
  Covey, Lirio S. ; Hu, Mei-Chen ; Winhusen, Theresa M. ; Lima, Jennifer ; Berlin, Ivan ; Nunes, Edward V.
 Journal of Substance Abuse Treatment 2015;59:104-108. [doi: 10.1016/j.jsat.2015.07.004].
 
29. Treatment Satisfaction in the CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Thomas, Christie ; Hillhouse, Maureen P. ; Ang, Alfonso ; Annon, Jeffrey J. ; Mooney, Larissa J. ; Hasson, Albert L. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Phoenix, AZ, June 13-18, 2015.
 
30. Treatment Strategy Profiles in Substance Use Disorder Treatment Programs: A Latent Class Analysis. doc type
  Edmond, Mary Bond ; Aletraris, Lydia ; Paino, Maria ; Roman, Paul M.
 Drug and Alcohol Dependence 2015;153:109-115. [doi: 10.1016/j.drugalcdep.2015.05.047].
 
31. Opioid Addicted Buprenorphine Injectors: Drug Use During and After 12-Weeks of Buprenorphine-Naloxone or Methadone in the Republic of Georgia. doc type
  Piralishvili, Gvantsa ; Otiashvili, David ; Sikharulidze, Zura ; Kamkamidze, George ; Poole, Sabrina A. ; Woody, George E.
 Journal of Substance Abuse Treatment 2015;50:32-37. [doi: 10.1016/j.jsat.2014.10.003].
 
32. A Systematic Approach to Subgroup Analyses in a Smoking Cessation Trial. doc type
  Westover, Arthur N. ; Kashner, T. Michael ; Winhusen, Theresa M. ; Golden, Richard M. ; Nakonezny, Paul A. ; Adinoff, Bryon H. ; Henley, Steven S.
 American Journal of Drug and Alcohol Abuse 2015;41(6):498-507. [doi: 10.3109/00952990.2015.1044605].
 
33. Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. doc type
  Schulte, Marya T. ; Hser, Yih-Ing ; Saxon, Andrew J. ; Evans, Elizabeth ; Li, Libo ; Huang, David ; Hillhouse, Maureen P. ; Thomas, Christie ; Ling, Walter
 Journal of Community Health 2015;40(5):940-947. [doi: 10.1007/s10900-015-0016-2].
 
34. Long-term Outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Provost, Scott E. ; Fitzmaurice, Garrett M. ; McDermott, Katherine A. ; Srisarajivakul, Emily N. ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; McHugh, R. Kathryn ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2015;150:112-119. [doi: 10.1016/j.drugalcdep.2015.02.030].
 
35. Opioid Withdrawal, Craving, and Use During and After Outpatient Buprenorphine Stabilization and Taper: A Discrete Survival and Growth Mixture Model. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Walker, N. Robrina ; Weiss, Roger D. ; Trivedi, Madhukar H.
 Addictive Behaviors 2015;41:20-28. [doi: 10.1016/j.addbeh.2014.09.021].
 
36. Denial of Urinalysis-Confirmed Opioid Use in Prescription Opioid Dependence. doc type
  Hilario, E. Yvette ; Griffin, Margaret L. ; McHugh, R. Kathryn ; McDermott, Katherine A. ; Connery, Hilary Smith ; Fitzmaurice, Garrett M. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):85-90. [doi: 10.1016/j.jsat.2014.07.003].
 
37. The Multi-Site Prescription Opioid Addiction Treatment Study: 18-Month Outcomes. doc type
  Potter, Jennifer Sharpe ; Dreifuss, Jessica A. ; Marino, Elise N. ; Provost, Scott E. ; Dodd, Dorian R. ; Rice, Lindsay S. ; Fitzmaurice, Garrett M. ; Griffin, Margaret L. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):62-69. [doi: 10.1016/j.jsat.2014.07.009].
 
38. Toward Personalized Smoking-Cessation Treatment: Using a Predictive Modeling Approach to Guide Decisions Regarding Stimulant Medication Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Smokers. doc type
  Luo, Sean X. ; Covey, Lirio S. ; Hu, Mei-Chen ; Levin, Frances R. ; Nunes, Edward V. ; Winhusen, Theresa M.
 American Journal on Addictions 2015;24(4):348-356. [doi: 10.1111/ajad.12193].
 
39. Initial Response as a Predictor of 12-Week Buprenorphine-Naloxone Treatment Response in a Prescription Opioid-Dependent Population. doc type
  McDermott, Katherine A. ; Griffin, Margaret L. ; Connery, Hilary Smith ; Hilario, E. Yvette ; Fiellin, David A. ; Fitzmaurice, Garrett M. ; Weiss, Roger D.
 Journal of Clinical Psychiatry 2015;76(2):189-194. [doi: 10.4088/JCP.14m09096].
 
40. Predictors of Long Term Opioid Withdrawal Outcome After Short-Term Stabilization with Buprenorphine. doc type
  Saleh, Mohammad I.
 European Review for Medical and Pharmacological Sciences 2014;18:3935-3942..
 
41. Training Addiction Professionals in Empirically Supported Treatments: Perspectives from the Treatment Community. doc type
  Hartzler, Bryan ; Rabun, Carl
 Substance Abuse 2014;35:30-36. [doi: 10.1080/08897077.2013.789816].
 
42. Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study. doc type
  Teruya, Cheryl ; Schwartz, Robert P. ; Mitchell, Shannon G. ; Hasson, Albert L. ; Thomas, Christie ; Buoncristiani, Samantha H. ; Hser, Yih-Ing ; Wiest, Katharina ; Cohen, Allan J. ; Glick, Naomi ; Jacobs, Petra ; McLaughlin, Paul ; Ling, Walter
 Journal of Psychoactive Drugs 2014;46(5):412-426. [doi: 10.1080/02791072.2014.921743].
 
43. Assessing Craving and Its Relationship to Subsequent Prescription Opioid Use Among Treatment-Seeking Prescription Opioid Dependent Patients. doc type
  McHugh, R. Kathryn ; Fitzmaurice, Garrett M. ; Carroll, Kathleen M. ; Griffin, Margaret L. ; Hill, Kevin P. ; Wasan, Ajay D. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2014;145:121-126. [doi: 10.1016/j.drugalcdep.2014.10.002].
 
44. Achieving Cannabis Cessation -- Evaluating N-Acetylcysteine Treatment (ACCENT): Design and Implementation of a Multi-Site, Randomized Controlled Study in the National Institute on Drug Abuse Clinical Trials Network. doc type
  McClure, Erin A. ; Sonne, Susan C. ; Winhusen, Theresa M. ; Carroll, Kathleen M. ; Ghitza, Udi E. ; McRae-Clark, Aimee L. ; Matthews, Abigail G. ; Sharma, Gaurav ; VanVeldhuisen, Paul C. ; Vandrey, Ryan G. ; Levin, Frances R. ; Weiss, Roger D. ; Lindblad, Robert ; Allen, Colleen ; Mooney, Larissa J. ; Haynes, Louise F. ; Brigham, Gregory S. ; Sparenborg, Steven ; Hasson, Albert L. ; Gray, Kevin M.
 Contemporary Clinical Trials 2014;39(2):211-223. [doi: 10.1016/j.cct.2014.08.011].
 
45. A Multi-Site, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence. doc type
  Winhusen, Theresa M.
 Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2014.
 
46. Osmotic-Release Methylphenidate Randomized Controlled Trial for Adolescents with Attention-Deficit/Hyperactivity Disorders and Substance Use Disorders: A Missing Data Sensitivity Analysis. doc type
  McPherson, Sterling ; Mamey, Mary Rose ; Barbosa-Leiker, Celestina ; Murphy, Sean ; Roll, John M.
 Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2014.
 
47. Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence. doc type doc type
  Winhusen, Theresa M. ; Kropp, Frankie B. ; Lindblad, Robert ; Douaihy, Antoine B. ; Haynes, Louise F. ; Hodgkins, Candace ; Chartier, Karen ; Kampman, Kyle M. ; Sharma, Gaurav ; Lewis, Daniel F. ; VanVeldhuisen, Paul C. ; Theobald, Jeff ; May, Jeanine ; Brigham, Gregory S.
 Journal of Clinical Psychiatry 2014;75(7):757-764. [doi: 10.4088/JCP.13m08862].
 
48. Improving Treatment for Opioid Dependence: A Perspective from the Ohio Valley Node of the NIDA Clinical Trials Network. doc type
  Winstanley, Erin L. ; Brigham, Gregory S. ; Babcock, Dean ; Winhusen, Theresa M.
 Progress in Community Health Partnerships: Research, Education, and Action 2014;8(1):99-107. [doi: 10.1353/cpr.2014.0002].
 
49. Who Benefits from Additional Drug Counseling Among Prescription Opioid Dependent Patients Receiving Buprenorphine-Naloxone and Standard Medical Management? doc type
  Weiss, Roger D. ; Griffin, Margaret L. ; Potter, Jennifer Sharpe ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; Connery, Hilary Smith ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2014;104(1):118-122. [doi: 10.1016/j.drugalcdep.2014.04.005].
 
50. HIV Risk Reduction with Buprenorphine-Naloxone or Methadone: Findings from A Randomized Trial. doc type
  Woody, George E. ; Bruce, R. Douglas ; Korthuis, P. Todd ; Chhatre, Sumedha ; Hillhouse, Maureen P. ; Jacobs, Petra ; Sorensen, James L. ; Saxon, Andrew J. ; Metzger, David S. ; Ling, Walter
 Journal of Acquired Immune Deficiency Syndromes 2014;66(3):288-293. [doi: 10.1097/QAI.0000000000000165].
 
51. Reasons for Opioid Use Among Patients with Dependence on Prescription Opioids: The Role of Chronic Pain. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; McHugh, R. Kathryn ; Haller, Deborah L. ; Jacobs, Petra ; Gardin, John G. II ; Fischer, Daniel ; Rosen, Kristen D.
 Journal of Substance Abuse Treatment 2014;47(2):140-145. [doi: 10.1016/j.jsat.2014.03.004].
 
52. Genetic Variation in OPRD1 and the Response to Treatment for Opioid Dependence with Buprenorphine in European American Females. doc type
  Clarke, Toni-Kim ; Crist, Richard C. ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade H.
 Pharmacogenomics Journal 2014;14:303-308. [doi: 10.1038/tpj.2013.30].
 
53. A Randomized Trial of Concurrent Smoking-Cessation and Substance Use Disorder Treatment in Stimulant-Dependent Smokers. doc type
  Winhusen, Theresa M. ; Brigham, Gregory S. ; Kropp, Frankie B. ; Lindblad, Robert ; Gardin, John G. II ; Penn, Patricia E. ; Hodgkins, Candace ; Kelly, Thomas M. ; Douaihy, Antoine B. ; McCann, Michael J. ; Love, Lee D. ; DeGravelles, Eliot ; Bachrach, Ken ; Sonne, Susan C. ; Hiott, Robert ; Haynes, Louise F. ; Sharma, Gaurav ; Lewis, Daniel F. ; VanVeldhuisen, Paul C. ; Theobald, Jeff ; Ghitza, Udi E.
 Journal of Clinical Psychiatry 2014;75(4):336-343. [doi: 10.4088/JCP.13m08449].
 
54. Baseline Characteristics and Treatment Outcomes in Prescription Opioid Dependent Patients With and Without Co-Occurring Psychiatric Disorder. doc type
  Griffin, Margaret L. ; Dodd, Dorian R. ; Potter, Jennifer Sharpe ; Rice, Lindsay S. ; Dickinson, William ; Sparenborg, Steven ; Weiss, Roger D.
 American Journal of Drug and Alcohol Abuse 2014;40(2):157-162. [doi: 10.3109/00952990.2013.842241].
 
55. Achieving Smoking Abstinence is Associated with Decreased Cocaine Use in Cocaine-Dependent Patients Receiving Smoking-Cessation Treatment. doc type
  Winhusen, Theresa M. ; Kropp, Frankie B. ; Theobald, Jeff ; Lewis, Daniel F.
 Drug and Alcohol Dependence 2014;134(1):391-395. [doi: 10.1016/j.drugalcdep.2013.09.019].
 
56. The Relationship Between Primary Prescription Opioid and Buprenorphine-Naloxone Induction Outcomes in a Prescription Opioid Dependent Sample. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen ; Weiss, Roger D. ; Mooney, Larissa ; Potter, Jennifer Sharpe ; Lee, Joshua ; Gourevitch, Marc N. ; Ling, Walter
 American Journal on Addictions 2014;23(4):343-348. [doi: 10.1111/j.1521-0391.2013.12105.x].
 
57. Treatment Retention Among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Saxon, Andrew J. ; Huang, David ; Hasson, Albert ; Thomas, Christie ; Hillhouse, Maureen ; Jacobs, Petra ; Teruya, Cheryl ; McLaughlin, Paul ; Wiest, Katharina ; Cohen, Allan J. ; Ling, Walter
 Addiction 2014;109(1):79-87. [doi: 10.1111/add.12333].
 
58. From START to Finish: National and International Perspectives on Disseminating Research to Practice for the Treatment of Opioid Dependence. doc type
  Saxon, Andrew J. ; Woody, George E. ; Jacobs, Petra ; Crist, Richard C. ; Nurhidayat, Adhi Wibowo ; Hickman, Mathew ; Strang, John
 Blending Initiative Workshop sponsored by the National Institute on Drug Abuse (NIDA), the National Drug Abuse Treatment Clinical Trials Network (CTN), and the NIDA/SAMHSA Blending Initiative in collaboration with the American Association for the Treatment of Opioid Dependence (AATOD), Philadelphia, PA, November 10, 2013.
 
59. Mirtazapine in Comorbid Major Depression and Alcohol Use Disorder: A Long-Term Follow-Up Study.
  Cornelius, Jack R. ; Douaihy, Antoine B. ; Clark, Duncan B. ; Daley, Dennis C. ; Chung, Tammy ; Wesesky, Maribeth A. ; Wood, D. Scott ; Salloum, Ihsan
 Journal of Addictive Behaviors, Therapy & Rehabilitation 2013;2:4. [doi: 10.4172/2324-9005.1000113].
 
60. Treating Nicotine Dependence by Targeting Attention Deficit/Hyperactivity Disorder (ADHD) with OROS Methylphenidate: The Role of Baseline ADHD Severity and Treatment Response. doc type
  Nunes, Edward V. ; Covey, Lirio S. ; Brigham, Gregory S. ; Hu, Mei-Chen ; Levin, Frances R. ; Somoza, Eugene C. ; Winhusen, Theresa M.
 Journal of Clinical Psychiatry 2013;74(10):983-990. [doi: 10.4088/JCP.12m08155].
 
61. Characterizing Smoking, Cessation Services, and Quit Interest Across Outpatient Substance Abuse Treatment Modalities. doc type
  McClure, Erin A. ; Acquavita, Shauna P. ; Dunn, Kelly E. ; Stoller, Kenneth B. ; Stitzer, Maxine L.
 Journal of Substance Abuse Treatment 2013;46(2):194-201. [doi: 10.1016/j.jsat.2013.07.009].
 
62. CTN Webinar: Developing Medication Assisted Treatment (MAT) Protocols. doc type
  Saxon, Andrew J.
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, July 17, 2013.
 
63. Lack of Association of Cannabis Use with Opioid Outcomes Among Opioid-Dependent Youth. doc type
  Hill, Kevin P. ; Bennett, Heather E. ; Griffin, Margaret L. ; Connery, Hilary Smith ; Fitzmaurice, Garrett M. ; Subramaniam, Geetha A. ; Woody, George E. ; Weiss, Roger D.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
64. Concordance Between Self-Report and Urine Drug Screen Data in Adolescent Opioid Dependent Clinical Trial Participants. doc type
  Wilcox, Claire E. ; Bogenschutz, Michael P. ; Nakazawa, Masato ; Woody, George E.
 Addictive Behaviors 2013;38(10):2568-2574. [doi: 10.1016/j.addbeh.2013.05.015].
 
65. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START). doc type
  Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
 Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..
 
66. 2013 Texas Addiction Research to Practice Conference. doc type doc type
  Stotts, Angela L. ; Walters, Scott ; Wakhlu, Sidarth
 Dissemination Conference sponsored by the Texas Node, Dallas, TX, April 26, 2013.
 
67. Transdisciplinary Collaboration and Endorsement of Pharmacological and Psychosocial Evidence-Based Practices by Medical and Psychosocial Substance Abuse Treatment Providers in the United States. doc type
  Pinto, Rogerio M. ; Spector, Anya Y. ; Yu, Gary ; Campbell, Aimee N. C.
 Drugs: Education, Prevention and Policy 2013;20(5):408-416. [doi: 10.3109/09687637.2013.783792].
 
68. Association of Cannabis Use with Opioid Outcomes Among Opioid-Dependent Youth. doc type
  Hill, Kevin P. ; Bennett, Heather E. ; Griffin, Margaret L. ; Connery, Hilary Smith ; Fitzmaurice, Garrett M. ; Subramaniam, Geetha A. ; Woody, George E. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2013;132(1-2):342-345. [doi: 10.1016/j.drugalcdep.2013.02.030].
 
69. An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans. doc type
  Crist, Richard C. ; Clarke, Toni-Kim ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade
 Neuropsychopharmacology 2013;38:2003-2010. [doi: 10.1038/npp.2013.99].
 
70. Patient Characteristics Associated with Buprenorphine/Naloxone Treatment Outcome for Prescription Opioid Dependence: Results from a Multisite Study. doc type
  Dreifuss, Jessica A. ; Griffin, Margaret L. ; Frost, Katherine ; Fitzmaurice, Garrett M. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Selzer, Jeffrey A. ; Hatch-Maillette, Mary A. ; Sonne, Susan C. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2013;131(1-2):112-118. [doi: 10.1016/j.drugalcdep.2012.12.010].
 
71. Gender Differences in a Clinical Trial for Prescription Opioid Dependence. doc type
  McHugh, R. Kathryn ; DeVito, Elise E. ; Dodd, Dorian ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Greenfield, Shelly F. ; Connery, Hilary Smith ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2013;45(1):38-43. [doi: 10.1016/j.jsat.2012.12.007].
 
72. Risk of Methylphenidate-Induced Prehypertension in Normotensive Adult Smokers with Attention Deficit Hyperactivity Disorder. doc type
  Westover, Arthur N. ; Nakonezny, Paul A. ; Winhusen, Theresa M. ; Adinoff, Bryon H. ; Vongpatanasin, Wanpen
 Journal of Clinical Hypertension 2013;15(2):124-132. [doi: 10.1111/jch.12039].
 
73. A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ling, Walter
 Journal of Addiction Medicine 2013;7(1):33-38. [doi: 10.1097/ADM.0b013e318277e92e].
 
74. Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology. doc type
  Mooney, Larissa J. ; Nielsen, Suzanne ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Stablein, Don ; McCormack, Jennifer ; Lindblad, Robert ; Ling, Walter
 Contemporary Clinical Trials 2013;34(2):196-204. [doi: 10.1016/j.cct.2012.11.002].
 
75. Osmotic Release Oral System Methylphenidate Prevents Weight Gain during a Smoking-Cessation Attempt in Adults with ADHD. doc type
  Heffner, Jaimee L. ; Lewis, Daniel F. ; Winhusen, Theresa M.
 Nicotine and Tobacco Research 2013;15(2):583-587. [doi: 10.1093/ntr/nts152].
 
76. Preliminary Evidence That Adherence to Counseling Mediates the Effects of Pretreatment Self-Efficacy and Motivation on Outcome of a Cessation Attempt in Smokers with ADHD. doc type
  Heffner, Jaimee L. ; Lewis, Daniel F. ; Winhusen, Theresa M.
 Nicotine & Tobacco Research 2013;15(2):393-400. [doi: 10.1093/ntr/nts135].
 
77. Buprenorphine/Naloxone and Methadone Effects on Laboratory Indices of Liver Health: A Randomized Trial. doc type doc type
  Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ang, Alfonso ; Doraimani, Geetha ; Tasissa, Gudaye ; Lokhnygina, Yuliya ; Leimberger, Jeffrey D. ; Bruce, R. Douglas ; McCarthy, John ; Wiest, Katharina ; McLaughlin, Paul ; Bilangi, Richard ; Cohen, Allan J. ; Woody, George E. ; Jacobs, Petra
 Drug and Alcohol Dependence 2013;128(1-2):71-76. [doi: 10.1016/j.drugalcdep.2012.08.002].
 
78. Financial Factors Associated with Implementation of Medications for Addiction Treatment (MAT) for Alcohol Use Disorders. doc type
  Knudsen, Hannah K. ; Roman, Paul M.
 Poster presented at the Addiction Health Services Research Conference (AHSR) conference, New York City, NY, October 17-19, 2012.
 
79. Predictors of Outcome After Short-Term Stabilization with Buprenorphine. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Ling, Walter
 Journal of Substance Abuse Treatment 2013;44(1):336-342. [doi: 10.1016/j.jsat.2012.08.016].
 
80. Mirtazapine in Comorbid Major Depression and Alcohol Dependence: An Open-Label Trial. doc type
  Cornelius, Jack R. ; Douaihy, Antoine B. ; Clark, Duncan B. ; Chung, Tammy ; Wood, D. Scott ; Daley, Dennis C.
 Journal of Dual Diagnosis 2012;8(3):200-204. [doi: 10.1080/15504263.2012.696527].
 
81. Financial Factors and the Implementation of Medications for Treating Opioid Use Disorders. doc type
  Knudsen, Hannah K. ; Roman, Paul M.
 Journal of Addictive Medicine 2012;6(4):280-286. [doi: 10.1097/ADM.0b013e318262a97a].
 
82. CTN Webinar: Co-Occurring Disorders: Integrated Treatment of Addiction and Mood and Anxiety Disorders. doc type
  Daley, Dennis C. ; Douaihy, Antoine B.
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, July 18, 2012.
 
83. Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World. doc type
  Winhusen, Theresa M. ; Brady, Kathleen T. ; Stitzer, Maxine L. ; Woody, George E. ; Lindblad, Robert ; Kropp, Frankie B. ; Brigham, Gregory S. ; Liu, David S. ; Sparenborg, Steven ; Sharma, Gaurav ; VanVeldhuisen, Paul C. ; Adinoff, Bryon H. ; Somoza, Eugene C.
 Contemporary Clinical Trials 2012;33(5):993-1002. [doi: 10.1016/j.cct.2012.05.003].
 
84. Predictors of Attrition with Buprenorphine/Naloxone Treatment in Opioid Dependent Youth. doc type
  Warden, Diane ; Subramaniam, Geetha A. ; Carmody, Thomas ; Woody, George E. ; Minhajuddin, Abu T. ; Poole, Sabrina A. ; Potter, Jennifer Sharpe ; Fishman, Marc J. ; Bogenschutz, Michael P. ; Patkar, Ashwin A. ; Trivedi, Madhukar H.
 Addictive Behaviors 2012;37(9):1046-1053. [doi: 10.1016/j.addbeh.2012.04.011].
 
85. 2012 Texas Research to Practice Conference: Learn how Science is Impacting Addiction Treatment. doc type doc type doc type
  Trivedi, Madhukar H. ; Crowell, A. Rebecca ; Denton, Douglas ; Kosten, Thomas ; Potter, Jennifer Sharpe ; Hien, Denise A. ; Spence, Richard ; Levy, Michael S. ; Muir, Joan A.
 Dissemination Conference sponsored by the Texas Node, Dallas, TX, April 30, 2012.
 
86. Accelerating Knowledge Exchange in Substance Abuse Treatment (NIDA Blending Conference). doc type doc type
 
 Sponsored by the National Institute on Drug Abuse, Atlanta, GA, April 19, 2012.
 
87. Buprenorphine Suite of Blending Products (Blending Team Product). doc type doc type
  Blending Team Members
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2005-2012.
 
88. Advances in Clinical Research for Prescription Opioid Dependence. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D.
 Presented at the National Association of Social Workers Massachusetts Chapter Symposium, Framingham, MA, March 29-30, 2012.
 
89. NIDA's Clinical Trials Network: A Source of Social Work Practice-Relevant Knowledge. doc type
  Wells, Elizabeth A. ; Daley, Dennis C.
 Presented at the Annual Meeting of the Society for Social Work and Research, Washington, DC, January 11-15, 2012.
 
90. Design Considerations for a Study to Evaluate the Impact of Smoking Cessation Treatment on Stimulant Use Outcomes in Stimulant-dependent Individuals. doc type
  Winhusen, Theresa M. ; Stitzer, Maxine L. ; Woody, George E. ; Brigham, Gregory S. ; Kropp, Frankie B. ; Ghitza, Udi E. ; Lindblad, Robert ; Adinoff, Bryon H. ; Green, Cindy ; Sharma, Gaurav ; Somoza, Eugene C.
 Contemporary Clinical Trials 2012;33(1):197-205. [doi: 10.1016/j.cct.2011.09.018].
 
91. Compensation Effects on Clinical Trial Data Collection in Opioid-Dependent Young Adults. doc type
  Wilcox, Claire E. ; Bogenschutz, Michael P. ; Nakazawa, Masato ; Woody, George E.
 American Journal of Drug and Alcohol Abuse 2012;38(1):81-86. [doi: 10.3109/00952990.2011.600393].
 
92. Major Depression and Treatment Response in Adolescents with ADHD and Substance Use Disorder. doc type
  Warden, Diane ; Riggs, Paula D. ; Min, Sung-Joon ; Mikulich-Gilbertson, Susan K. ; Tamm, Leanne ; Trello-Rishel, Kathlene ; Winhusen, Theresa M.
 Drug and Alcohol Dependence 2012;120(1-3):214-219. [doi: 10.1016/j.drugalcdep.2011.08.001].
 
93. Attention-Deficit/Hyperactivity Disorder Subtypes in Adolescents with Comorbid Substance-Use Disorder. doc type
  Tamm, Leanne ; Adinoff, Bryon H. ; Nakonezny, Paul A. ; Winhusen, Theresa M. ; Riggs, Paula D.
 American Journal of Drug and Alcohol Abuse 2012;38(1):93-100. [doi: 10.3109/00952990.2011.600395].
 
94. Protocol: NIDA-CTN-0027: Starting Treatment with Agonist Replacement Therapies (START). doc type
  Ling, Walter ; Saxon, Andrew J.
 Presented at the American Public Health Association (APHA) annual meeting, Washington, DC, Oct. 28 - Nov. 2, 2011.
 
95. Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth. doc type
  Subramaniam, Geetha A. ; Warden, Diane ; Minhajuddin, Abu T. ; Fishman, Marc J. ; Stitzer, Maxine L. ; Adinoff, Bryon H. ; Trivedi, Madhukar H. ; Weiss, Roger D. ; Potter, Jennifer Sharpe ; Poole, Sabrina A. ; Woody, George E.
 Journal of the American Academy of Child & Adolescent Psychiatry 2011;50(11):1120-1128. [doi: 10.1016/j.jaac.2011.07.010].
 
96. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. doc type doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Byrne, Mimmie ; Connery, Hilary Smith ; Dickinson, William ; Gardin, John G. II ; Griffin, Margaret L. ; Gourevitch, Marc N. ; Haller, Deborah L. ; Hasson, Albert L. ; Huang, Zhen ; Jacobs, Petra ; Kosinski, Andrzej S. ; Lindblad, Robert ; McCance-Katz, Elinore F. ; Provost, Scott E. ; Selzer, Jeffrey A. ; Somoza, Eugene C. ; Sonne, Susan C. ; Ling, Walter
 Archives of General Psychiatry 2011;68(12):1238-1246. [doi: 10.1001/archgenpsychiatry.2011.121].
 
97. Selective Review and Commentary on Emerging Pharmacotherapies for Opioid Addiction. doc type
  Ling, Walter ; Mooney, Larissa ; Zhao, Min ; Nielsen, Suzanne ; Torrington, Matthew ; Miotto, Karen
 Substance Abuse and Rehabilitation 2011;2:181-188. [doi: 10.2147/SAR.S20895].
 
98. Depressive Symptoms, Substance Use and HIV-Related High Risk Behaviors among Opioid-Dependent Individuals: Results from the Clinical Trials Network. doc type
  Pilowsky, Daniel J. ; Wu, Li-Tzy ; Burchett, Bruce ; Blazer, Dan G. ; Ling, Walter
 Substance Use & Misuse 2011;46(14):1716-1725. [doi: 10.3109/10826084.2011.611960].
 
99. Barriers to Implementing MAT. doc type
  Winstanley, Erin L.
 Presented at the South Dakota Association of Addiction & Prevention Specialists conference, Mitchell, SD, September 28-30, 2011.
 
100. An Exploration of Site Effects in a Multisite Trial of OROS-Methylphenidate for Smokers with Attention Deficit/Hyperactivity Disorder. doc type
  Covey, Lirio S. ; Hu, Mei-Chen ; Green, Carla A. ; Brigham, Gregory S. ; Hurt, Richard D. ; Adler, Lenard A. ; Winhusen, Theresa M.
 American Journal of Drug and Alcohol Abuse 2011;37(5):392-399. [doi: 10.3109/00952990.2011.596979].
 
101. Participant Characteristics and Buprenorphine Dose. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Doraimani, Geetha ; Thomas, Christie ; Hasson, Albert L. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):453-459. [doi: 10.3109/00952990.2011.596974].
 
102. Assessing Drug Use during Follow-Up: Direct Comparison of Candidate Outcome Definitions in Pooled Analyses of Addiction Treatment Studies. doc type
  Korte, Jeffrey E. ; Magruder, Kathryn M. ; Chiuzan, Codruta C. ; Logan, Sarah L. ; Killeen, Therese ; Bandyopadhyay, Dipankar ; Brady, Kathleen T.
 American Journal of Drug and Alcohol Abuse 2011;37(5):358-366. [doi: 10.3109/00952990.2011.602997].
 
103. Strategies for Safety Reporting in Substance Abuse Trials. doc type
  Lindblad, Robert ; Campanella, Maria ; Styers, David ; Kothari, Prasad ; Sparenborg, Steven ; Rosa, Carmen L.
 American Journal of Drug and Alcohol Abuse 2011;37(5):440-445. [doi: 10.3109/00952990.2011.602996].
 
104. Smoking Cessation Treatment among Patients in Community-Based Substance Abuse Rehabilitation Programs: Exploring Predictors of Outcome as Clues Toward Treatment Improvement. doc type
  Reid, Malcolm S. ; Jiang, Huiping ; Fallon, Bryan ; Sonne, Susan C. ; Rinaldi, Paul ; Turrigiano, Eva ; Arfken, Cynthia L. ; Robinson, James A. ; Rotrosen, John ; Nunes, Edward V.
 American Journal of Drug and Alcohol Abuse 2011;37(5):472-478. [doi: 10.3109/00952990.2011.596981].
 
105. A Multi-Level Analysis of Counselor Attitudes Toward the Use of Buprenorphine in Substance Abuse Treatment. doc type
  Rieckmann, Traci R. ; Kovas, Anne E. ; McFarland, Bentson H. ; Abraham, Amanda J.
 Journal of Substance Abuse Treatment 2011;41(4):374-385. [doi: 10.1016/j.jsat.2011.05.005].
 
106. Subjective Effects, Misuse, and Adverse Effects of Osmotic-Release Methylphenidate Treatment in Adolescent Substance Abusers with Attention Deficit Hyperactivity Disorder (ADHD). doc type
  Winhusen, Theresa M. ; Lewis, Daniel F. ; Riggs, Paula D. ; Davies, Robert D. ; Adler, Lenard A. ; Sonne, Susan C. ; Somoza, Eugene C.
 Journal of Child and Adolescent Psychopharmacology 2011;21(5):455-463. [doi: 10.1089/cap.2011.0014].
 
107. Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Connery, Hilary Smith ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Hollywood, FL, June 18-23, 2011.
 
108. Divergence by ADHD Subtype in Smoking Cessation Response to OROS-Methylphenidate. doc type
  Covey, Lirio S. ; Hu, Mei-Chen ; Weissman, Judith ; Croghan, Ivana T. ; Adler, Lenard A. ; Winhusen, Theresa M.
 Nicotine and Tobacco Research 2011;13(10):1003-1008. [doi: 10.1093/ntr/ntr087].
 
109. Cocaine Use Reduction with Buprenorphine (CURB: CTN-0048): Protocol Overview. doc type
  Mooney, Larissa ; Saxon, Andrew J. ; Ling, Walter
 Webinar sponsored by the NIDA Clinical Coordinating Center, May 11, 2011.
 
110. Cigarette and Cannabis Use Trajectories among Adolescents in Treatment for Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders. doc type
  Gray, Kevin M. ; Riggs, Paula D. ; Min, Sung-Joon ; Mikulich-Gilbertson, Susan K. ; Bandyopadhyay, Dipankar ; Winhusen, Theresa M.
 Drug and Alcohol Dependence 2011;117(2-3):242-247. [doi: 10.1016/j.drugalcdep.2011.02.005].
 
111. Trajectories of Nicotine and Cannabis Use among Adolescents in Treatment for ADHD and Substance Use Disorders. doc type
  Gray, Kevin M. ; Riggs, Paula D. ; Min, Sung-Joon ; Mikulich-Gilbertson, Susan K. ; Bandyopadhyay, Dipankar ; Winhusen, Theresa M.
 Poster presented at the Society for Research on Nicotine and Tobacco conference, Toronto, Canada, February 16-19, 2011.
 
112. Using Medication-Assisted Treatment for Substance Use Disorders: Evidence of Barriers and Facilitators of Implementation. doc type
  Roman, Paul M. ; Abraham, Amanda J. ; Knudsen, Hannah K.
 Addictive Behaviors 2011;36(6):584-589. [doi: 10.1016/j.addbeh.2011.01.032].
 
113. Clinical Correlates of Health-Related Quality of Life Among Opioid-Dependent Patients. doc type
  Heslin, Kevin C. ; Stein, Judith A. ; Heinzerling, Keith G. ; Pan, Deyu ; Magladry, Christine ; Hays, Ron D.
 Quality of Life Research 2011;20(8):1205-1213. [doi: 10.1007/s11136-011-9858-y].
 
114. Counselors’ Knowledge of the Adoption of Tobacco Cessation Medications in Substance Abuse Treatment Programs. doc type
  Rothrauff, Tanja C. ; Eby, Lillian T.
 American Journal on Addictions 2011;20(1):56-62 [doi: 10.1111/j.1521-0391.2010.00095.x].
 
115. What the National Institute on Drug Abuse's Clinical Trials Network Can Do For You? Major Findings from Medication Trials and Implications for Community-Based Settings. doc type
  Weiss, Roger D.
 Presented at the NIATx Summit and State Associations of Addiction Services (SAAS) National Conference, Boston, MA, July 19-22, 2011.
 
116. A Community-Based, Two-Phase Randomized Controlled Trial of Buprenorphine With and Without Individual Drug Counseling for the Treatment of Opioid Analgesic Addiction. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D. ; Jacobs, Petra ; Ling, Walter
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010..
 
117. NIDA Clinical Trials Network: Examples of Community Program Buprenorphine Dissemination in Low-Access Areas. doc type
  Connery, Hilary Smith ; Publicker, Mark ; Hoyne, Jim ; Cohan, Allison ; Provost, Scott E. ; Woody, George E. ; Weiss, Roger D.
 Poster presented at the American Academy of Addiction Psychiatry (AAAP) annual meeting, Boca Raton, FL, December 2-5, 2010.
 
118. Data from the CTN Platform Study: Major Findings. doc type
  Roman, Paul M. ; Abraham, Amanda J.
 Presentation from the CTN Steering Committee Meeting, March 2009; CTN 10th Anniversary Symposium, 2010, and the CTN Steering Committee Meeting, September 2010.
 
119. Gender and Racial/Ethnic Differences in Addiction Severity, HIV Risk, and Quality of Life among Adults in Opioid Detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network. doc type
  Wu, Li-Tzy ; Ling, Walter ; Burchett, Bruce ; Blazer, Dan G. ; Shostak, Jack ; Woody, George E.
 Substance Abuse and Rehabilitation 2010;1:13-22. [doi: 10.2147/SAR.S15151].
 
120. Standardizing and Streamlining Safety Reporting in Substance Abuse Trials. doc type
  Lindblad, Robert ; Campanella, Maria ; Styers, David ; Kothari, Prasad ; Sparenborg, Steven ; Rosa, Carmen L.
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010.
 
121. Methods for Disseminating Evidence-based Treatments from the Frontlines of Community Treatment Programs (3rd edition). doc type doc type
  Douaihy, Antoine B. ; Hamilton, John A. ; Zammarelli, Lucy ; Tajima, Barbara M. ; Moskowitz, Martin ; McEntee, Seamus ; Obert, Jeanne L.
 Research Utilization Committee Dissemination Workshop held at the CTN Steering Committee meeting, Bethesda, MD, September 21, 2010.
 
122. Stimulant Treatment Doesn't Aggravate Substance Abuse. doc type
  Yan, Jun
 Psychiatric News 2010;45(3):3.
 
123. Cost-Effectiveness of Extended Buprenorphine-Naloxone Treatment for Opioid-Dependent Youth: Data from a Randomized Trial. doc type
  Polsky, Daniel ; Glick, Henry A. ; Yang, Jianing ; Subramaniam, Geetha A. ; Poole, Sabrina A. ; Woody, George E.
 Addiction 2010;105(9):1616-1624. [doi: 10.1111/j.1360-0443.2010.03001.x].
 
124. Does Improvement in Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) Mediate an Effect of Long-Acting OROS-Methylphenidate on Cigarette Smoking? A Secondary Analysis of CTN-0029. doc type
  Nunes, Edward V. ; Covey, Lirio S. ; Hu, Mei-Chen ; Pavlicova, Martina ; Somoza, Eugene C. ; Winhusen, Theresa M.
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
125. Counselor Attitudes toward Buprenorphine in the Clinical Trials Network. doc type
  Knudsen, Hannah K. ; Roman, Paul M.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
126. Comparison of Opiate-Primary Treatment Seekers With and Without Alcohol Use Disorder. doc type
  Hartzler, Bryan ; Donovan, Dennis M. ; Huang, Zhen
 Journal of Substance Abuse Treatment 2010;39(2):114-123. [doi: 10.1016/j.jsat.2010.05.008].
 
127. Effects of Participant Compensation Amounts on Missing Data and Urine Screen Results Among Adolescent and Young Adult Opioid Dependent Clinical Trial Participants. doc type
  Wilcox, Claire E. ; Bogenschutz, Michael P. ; Nakazawa, Masato ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
128. Craving Intensity and Withdrawal Severity Across Phases of Opioid Detoxification with Buprenorphine. doc type
  Chen, Hanhui ; Hillhouse, Maureen P. ; Doraimani, Geetha ; Hasson, Albert L. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
129. START Study Retention: Perspectives of Suboxone Dropouts. doc type
  Teruya, Cheryl ; Thomas, Christie ; Rosensteel, Anya ; Hasson, Albert L. ; Hillhouse, Maureen P. ; Hser, Yih-Ing ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
130. Concordance Between Self-Report and Urine Drug Screen Data in Adolescent Opioid Dependent Clinical Trial Participants. doc type
  Nakazawa, Masato ; Wilcox, Claire E. ; Bogenschutz, Michael P. ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
131. Implementing Research in Community Treatment Programs: Findings from a CTN Trial. doc type
  Cohen, Allan J. ; George, Dan ; Langlois, Camille ; Moreno, Ann ; Yomjinda, Dara ; Boubion, Cynthia ; Martin, Judith ; Donovick, Roger ; Thomas, Christie ; Hasson, Albert L. ; Vimieiro, Cintia ; Hillhouse, Maureen P. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
132. Cutting Edge Addiction Treatment Tools from NIDA's Clinical Trials Network. doc type doc type
  Olsen, Yngveld ; Fingerhood, Michael ; Fishman, Marc J. ; Beiting, Jim ; Sheidow, Ashli ; Higgins, Christine ; Lamb, Roland ; Dennis, Michael ; McKay, James R. ; Kemp, Jack ; Stitzer, Maxine L. ; Woody, George E.
 Dissemination Workshop, sponsored by the Mid-Atlantic Node, Baltimore, MD, June 3-4, 2010.
 
133. Association of Race and Ethnicity with Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy. doc type
  Brown, E. Sherwood ; Tirado, Carlos F. ; Minhajuddin, Abu T. ; Hillhouse, Maureen P. ; Adinoff, Bryon H. ; Ling, Walter ; Doraimani, Geetha ; Thomas, Christie
 Journal of Ethnicity in Substance Abuse 2010;9(2):106-114. [doi: 10.1080/15332641003772587].
 
134. Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial. doc type doc type
  Winhusen, Theresa M. ; Somoza, Eugene C. ; Brigham, Gregory S. ; Liu, David S. ; Green, Carla A. ; Covey, Lirio S. ; Croghan, Ivana T. ; Adler, Lenard A. ; Weiss, Roger D. ; Leimberger, Jeffrey D. ; Lewis, Daniel F. ; Dorer, Emily M.
 Journal of Clinical Psychiatry 2010;71(12):1680-1688. [doi: 10.4088/JCP.09m05089gry].
 
135. Feasibility of Conducting Genetics Research at Community Treatment Programs. doc type
  Sonne, Susan C. ; Gentilin, Stephanie ; Sampson, Royce ; DeVane, Lindsay ; Thomas, Christie ; Berrettini, Wade
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
136. The Internal and External Impacts of the Clinical Trials Network: A View from a Longitudinal Platform Study. doc type
  Roman, Paul M. ; Abraham, Amanda J. ; Knudsen, Hannah K. ; Ducharme, Lori J. ; Rothrauff, Tanja C. ; Savage, Sarah A.
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
137. Cost-Effectiveness of Extended Buprenorphine/Naloxone Treatment for Opioid Dependent Youth: Data from a Randomized Trial. doc type
  Polsky, Daniel ; Glick, Henry A. ; Yang, Jianing ; Subramaniam, Geetha A. ; Poole, Sabrina A. ; Woody, George E.
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
138. Adoption of Medication Treatment for Adolescent and Young Adult Opioid Dependence. doc type
  Fishman, Marc J. ; Khan, Lawangeen ; Garrett, Shannon ; O'Neill, Lawrence ; Hiken, Lauren ; Shah, Syed ; Bokhari, Asad
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
139. Substance Dependence and Co-Occurring Psychiatric Disorders: Best Practices for Diagnosis and Clinical Treatment. doc type
  CTN Co-occurring Disorders Special Interest Group ; Nunes, Edward V. ; Selzer, Jeffrey A. ; Levounis, Petros ; Davies, Carrie A.
 Kingston, NJ: Civic Research Institute, 2010, 632pp. ISBN: 1-887554-66-1.
 
140. OROS-Methylphenidate or Placebo for Adult Smokers with Attention Deficit Hyperactivity Disorder: Racial/Ethnic Differences. doc type
  Covey, Lirio S. ; Hu, Mei-Chen ; Winhusen, Theresa M. ; Weissman, Judith ; Berlin, Ivan ; Nunes, Edward V.
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
141. Smoking Cessation Research and the NIDA Clinical Trials Network. doc type
  Henningfield, Jack E.
 Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010.
 
142. CTN Pharmacotherapy Trials and the CTP. doc type
  Cohen, Allan J.
 Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010.
 
143. Adoption of Evidence-Based Practices in the CTN. doc type
  Roman, Paul M. ; Abraham, Amanda J.
 Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010.
 
144. Ten Years of Pharmacotherapy Trials in the CTN: An Overview. doc type
  Brady, Kathleen T.
 Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010.
 
145. Buprenorphine Treatment for Young Adults (Blending Team Product). doc type
  McNicholas, Laura F. ; Bogenschutz, Michael P. ; Subramaniam, Geetha A. ; Garrett, Shannon ; Storti, Susan A. ; Woody, George E. ; Freese, Thomas E. ; Waters, Pamela ; Durham, Thomas
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2010.
 
146. HIV Risk Behavior in Treatment-Seeking Opioid-Dependent Youth: Results from a NIDA Clinical Trials Network Multisite Study. doc type
  Meade, Christina S. ; Weiss, Roger D. ; Fitzmaurice, Garrett M. ; Poole, Sabrina A. ; Subramaniam, Geetha A. ; Patkar, Ashwin A. ; Connery, Hilary Smith ; Woody, George E.
 Journal of Acquired Immune Deficiency Syndromes 2010;55(1):65-72. [doi: 10.1097/QAI.0b013e3181d916db].
 
147. Buprenorphine Treatment of Prescription Opiate Addiction. doc type
  McCarthy, John
 Presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
148. Young Opioid Abusers Benefit from Extended Buprenorphine-Naloxone Treatment. doc type
  Whitten, Lori
 NIDA Notes 2010;23(1):8-9.
 
149. The First Decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the Gap Between Research and Practice to Improve Drug Abuse Treatment. doc type
  Tai, Betty ; Straus, Michele M. ; Liu, David S. ; Sparenborg, Steven ; Jackson, T. Ronald ; McCarty, Dennis
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S4-S13. [doi: 10.1016/j.jsat.2010.01.011].
 
150. Study Results from the Clinical Trials Network's First 10 Years: Where Do They Lead? doc type
  Wells, Elizabeth A. ; Saxon, Andrew J. ; Calsyn, Donald A. ; Jackson, T. Ronald ; Donovan, Dennis M.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S14-S30. [doi: 10.1016/j.jsat.2009.12.009].
 
151. A Longitudinal Study of Organizational Formation, Innovation of Adoption, and Dissemination Activities within the National Drug Abuse Treatment Clinical Trials Network. doc type
  Roman, Paul M. ; Abraham, Amanda J. ; Rothrauff, Tanja C. ; Knudsen, Hannah K.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S44-S52. [doi: 10.1016/j.jsat.2009.12.008].
 
152. From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. doc type
  Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].
 
153. Pain and Continued Opioid Use in Individuals Receiving Buprenorphine-Naloxone for Opioid Detoxification: Secondary Analyes from the Clinical Trials Network. doc type
  Potter, Jennifer Sharpe ; Chakrabarti, Amit ; Domier, Catherine P. ; Hillhouse, Maureen P. ; Weiss, Roger D. ; Ling, Walter
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S80-S86. [doi: 10.1016/j.jsat.2009.12.007].
 
154. OROS-Methylphenidate or Placebo for Adult Smokers with Attention Deficit Hyperactivity Disorder: Racial/Ethnic Differences. doc type
  Covey, Lirio S. ; Hu, Mei-Chen ; Winhusen, Theresa M. ; Weissman, Judith ; Berlin, Ivan ; Nunes, Edward V.
 Drug and Alcohol Dependence 2010;110(1-2):156-159. [doi: 10.1016/j.drugalcdep.2010.02.002].
 
155. Provision of Ancillary Medications During Buprenorphine Detoxification Does Not Improve Treatment Outcomes. doc type
  Hillhouse, Maureen P. ; Domier, Catherine P. ; Chim, David ; Ling, Walter
 Journal of Addictive Diseases 2010;29(1):23-29. [doi: 10.1080/10550880903438925].
 
156. A Method to Diagnose Opioid Dependence Resulting from Heroin Versus Prescription Opioids Using the Composite International Diagnostic Interview. doc type
  Potter, Jennifer Sharpe ; Prather, Kristi ; Kropp, Frankie B. ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Mohamedi, Nadia ; Copersino, Marc L. ; Weiss, Roger D.
 Contemporary Clinical Trials 2010;31(2):185-188. [doi: 10.1016/j.cct.2010.01.002].
 
157. Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Copersino, Marc L. ; Prather, Kristi ; Jacobs, Petra ; Provost, Scott E. ; Chim, David ; Selzer, Jeffrey A. ; Ling, Walter
 American Journal on Addictions 2010;19(2):141-146. [doi: 10.1111/j.1521-0391.2009.00017.x].
 
158. Effects of Buprenorphine and Hepatitis C on Liver Enzymes in Adolescents and Young Adults. doc type
  Bogenschutz, Michael P. ; Abbott, Patrick J. ; Kushner, Robert ; Tonigan, J. Scott ; Woody, George E.
 Journal of Addiction Medicine 2010;4(4):211-216. [doi: 10.1097/ADM.0b013e3181c4e27e].
 
159. The Relationship Between Depression and Smoking Cessation Outcomes in Treatment-Seeking Substance Abusers. doc type
  Sonne, Susan C. ; Nunes, Edward V. ; Jiang, Huiping ; Tyson, Clare ; Rotrosen, John ; Reid, Malcolm S.
 American Journal on Addictions 2010;19(2):111-8. [doi: 10.1111/j.1521-0391.2009.00015.x].
 
160. The Adoption of Alcohol Pharmacotherapies in the Clinical Trials Network: The Influence of Research Network Participation. doc type
  Abraham, Amanda J. ; Knudsen, Hannah K. ; Rothrauff, Tanja C. ; Roman, Paul M.
 Journal of Substance Abuse Treatment 2010;38(3):275-283. [doi: 10.1016/j.jsat.2010.01.003].
 
161. A Multi-Site, Two-Phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, Design, and Methodology. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Huang, Zhen ; Jacobs, Petra ; Hasson, Albert L. ; Lindblad, Robert ; Connery, Hilary Smith ; Prather, Kristi ; Ling, Walter
 Contemporary Clinical Trials 2010;31(2):189-199. [doi: 10.1016/j.cct.2010.01.003].
 
162. Medical and Mental Health Status Among Drug Dependent Patients Participating in a Smoking Cessation Treatment Study. doc type
  Lima, Jennifer E. ; Reid, Malcolm S. ; Smith, Jennifer L. ; Zhang, Yulei ; Jiang, Huiping ; Rotrosen, John ; Nunes, Edward V.
 Journal of Drug Issues 2009;39(2):293-312. [doi: 10.1177/002204260903900204].
 
163. Gender Differences at Presentation for Treatment-Seeking Opiate Dependence. doc type
  Haynes, Louise F. ; Carter, Rickey E. ; Back, Sudie E. ; Payne, Rebecca ; Hillhouse, Maureen P.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
164. Methods of Recruiting Adolescents with Psychiatric and Substance Use Disorders for a Clinical Trial. doc type
  Jaffee, William B. ; Bailey, Genie L. ; Lohman, Michelle ; Riggs, Paula D. ; McDonald, Leah ; Weiss, Roger D.
 American Journal of Drug and Alcohol Abuse 2009;35(5):381-384. [doi: 10.1080/00952990903150860].
 
165. Buprenorphine Adoption in the National Drug Abuse Treatment Clinical Trials Network. doc type
  Knudsen, Hannah K. ; Abraham, Amanda J. ; Johnson, J. Aaron ; Roman, Paul M.
 Journal of Substance Abuse Treatment 2009;37(3):307-312. [doi: 10.1016/j.jsat.2008.12.004].
 
166. Use of an Adaptive Treatment Research Design in a CTN Study of Prescription Opioid Dependence Treatment. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
167. Understanding Attitudes Toward Use of Medication in Substance Abuse Treatment: A Multilevel Approach. doc type
  Fitzgerald, John P. ; McCarty, Dennis
 Psychological Services 2009;6(1):74-84. [doi: 10.1037/a0013420].
 
168. Predictors of Outcome for Short-Term Medically Supervised Opioid Withdrawal During a Randomized, Multicenter Trial of Buprenorphine-Naloxone and Clonidine in the NIDA Clinical Trials Network. doc type
  Ziedonis, Douglas M. ; Amass, Leslie ; Steinberg, Marc ; Woody, George E. ; Krejci, Jonathan ; Annon, Jeffrey J. ; Cohen, Allan J. ; Waite-O'Brien, Nancy ; Stein, Susan M. ; McCarty, Dennis ; Reid, Malcolm S. ; Brown, Lawrence S. Jr. ; Maslansky, Robert ; Winhusen, Theresa M. ; Babcock, Dean ; Brigham, Gregory S. ; Muir, Joan A. ; Orr, Deborah ; Buchan, Betty J. ; Horton, Terry ; Ling, Walter
 Drug and Alcohol Dependence 2009;99(1-3):28-36. [doi: 10.1016/j.drugalcdep.2008.06.016].
 
169. Buprenorphine Tapering Schedule and Illicit Opioid Use. doc type doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Domier, Catherine P. ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert L. ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard
 Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x].
 
170. Extended vs. Short-Term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial. doc type doc type
  Woody, George E. ; Poole, Sabrina A. ; Subramaniam, Geetha A. ; Dugosh, Karen L. ; Bogenschutz, Michael P. ; Abbott, Patrick J. ; Patkar, Ashwin A. ; Publicker, Mark ; McCain, Karen ; Potter, Jennifer Sharpe ; Forman, Robert F. ; Vetter, Victoria ; McNicholas, Laura F. ; Blaine, Jack D. ; Lynch, Kevin G. ; Fudala, Paul
 JAMA 2008;300(17):2003-2011. [doi: 10.1001/jama.2008.574].
 
171. Opioid Treatment Programs in the Clinical Trials Network: Representativeness and Buprenorphine Adoption. doc type
  Ducharme, Lori J. ; Roman, Paul M.
 Journal of Substance Abuse Treatment 2009;37(1):90-94. [doi: 10.1016/j.jsat.2008.09.003].
 
172. Changes in 12-Step Cognitions Among Treatment-Seeking Adolescents. doc type
  Tonigan, J. Scott ; Forcehimes, Alyssa A. ; Bogenschutz, Michael P.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2008.
 
173. Effects of Buprenorphine and Hepatitis C on Liver Enzymes in Adolescents and Young Adults. doc type
  Bogenschutz, Michael P. ; Kushner, Robert ; Tonigan, J. Scott ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2008.
 
174. Relationship Between Therapeutic Alliance and Treatment Outcome in Opioid Dependent Adolescents and Young Adults Treated with Buprenorphine. doc type
  Forcehimes, Alyssa A. ; Bogenschutz, Michael P. ; Tonigan, J. Scott ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2008.
 
175. Evidence for 12-Step Facilitation and Combining Evidence Based Therapies: Use of TSF with Suboxone Treatment. doc type
  Donovan, Dennis M. ; Byrne, Mimmie
 Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008..
 
176. Understanding and Utilizing Buprenorphine in the Treatment and Short Term Detox of Opioid Addiction. doc type
  Freese, Thomas E. ; Detmer, Mary Ann ; Brigham, Gregory S.
 Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.
 
177. Addiction Treatments of the Future: The Role of Genetics. doc type
  Kreek, Mary Jeanne ; Haynes, Louise F. ; Cohen, Allan J.
 Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.
 
178. A Randomized Controlled Trial of Fluoxetine and Cognitive Behavioral Therapy in Adolescents with Major Depression, Behavior Problems, and Substance Use Disorders. doc type
  Riggs, Paula D. ; Mikulich-Gilbertson, Susan K. ; Davies, Robert D. ; Lohman, Michelle ; Klein, Constance ; Stover, Shannon K.
 Archives of Pediatrics & Adolescent Medicine 2007;161(11):1026-1034.
 
179. Statistical Methodology for a SMART Design in the Development of Adaptive Treatment Strategies. doc type
  Scott, Alena I. ; Levy, Janet A. ; Murphy, Susan A.
 State College, PA : The Methodology Center, Pennsylvania State University, Technical Report #07-82, 2007, 30p..
 
180. Integrating Services Research into CTN Clinical Trials: The Synergy is in the Details. doc type
  Perl, Harold I.
 Presented at the Addiction Health Services Research Conference, October 15-17, 2007, Athens, GA.
 
181. A Federal Effort to Bridge the Gap: NIDA's Blending Initiative Places Community Providers at the Leading Edge of New Treatment Knowledge. doc type
  Condon, Timothy P.
 Addiction Professional 2007;5(5):26-31.
 
182. The Science of Treatment: Dissemination of Research-Based Drug Addiction Treatment Findings (Blending Team Product). doc type
  National Institute on Drug Abuse (NIDA) ; Substance Abuse and Mental Health Services Administration (SAMHSA) ; Addiction Technology Transfer Center (ATTC) National Office
 Produced by the NIDA/SAMHSA-ATTC Blending Initiative, 2007.
 
183. Implementation of a Smoking Cessation Treatment Study at Substance Abuse Rehabilitation Programs: Smoking Behavior and Treatment Feasibility Across Varied Community-Based Outpatient Programs. doc type
  Reid, Malcolm S. ; Fallon, Bryan ; Sonne, Susan C. ; Nunes, Edward V. ; Lima, Jennifer ; Jiang, Huiping ; Tyson, Clare ; Hiott, Robert ; Arfken, Cynthia L. ; Bohs, Rhonda ; Orr, Deborah ; Muir, Joan A. ; Pihlgren, Eric ; Loree, Amy ; Fuller, Bret E. ; Giordano, Louis ; Robinson, James A. ; Rotrosen, John
 Journal of Addiction Medicine 2007;1(3):154-160.
 
184. Smoking Cessation Treatment in Community-Based Substance Abuse Rehabilitation Programs. doc type doc type
  Reid, Malcolm S. ; Fallon, Bryan ; Sonne, Susan C. ; Flammino, Frank ; Nunes, Edward V. ; Jiang, Huiping ; Kourniotis, Eva ; Lima, Jennifer ; Brady, Ronald ; Burgess, Cynthia ; Arfken, Cynthia L. ; Pihlgren, Eric ; Giordano, Louis ; Starosta, Aron ; Robinson, James A. ; Rotrosen, John
 Journal of Substance Abuse Treatment 2008;35(1):68-77. [doi: 10.1016/j.jsat.2007.08.010].
 
185. Research Network Involvement and Addiction Treatment Center Staff: Counselor Attitudes toward Buprenorphine. doc type
  Knudsen, Hannah K. ; Ducharme, Lori J. ; Roman, Paul M.
 American Journal on Addictions 2007;16(5):365-371 [doi: 10.1080/10550490701525418].
 
186. The Value of Ongoing Evaluation in Adopting Buprenorphine-Naloxone Short-Term Taper. doc type
  Brigham, Gregory S.
 Presented at the American Psychological Association (APA) Annual Convention, San Francisco, CA, August 17-20, 2007.
 
187. Smoking Cessation Treatment at Community-Based Substance Abuse Rehabilitation Programs : Impact on Cigarette Smoking. doc type
  Reid, Malcolm S. ; Fallon, Bryan ; Sonne, Susan C. ; Hiott, Robert ; Flammino, Frank ; Nunes, Edward V. ; Kourniotis, Eva ; Brady, Ronald ; Rinaldi, Paul ; Jiang, Huiping ; Arfken, Cynthia L. ; Pihlgren, Eric ; Giordano, Louis ; Robinson, James A. ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Quebec City, Canada, June 16-21, 2007.
 
188. Effect of Depression on Smoking Cessation Outcomes. doc type
  Sonne, Susan C. ; Nunes, Edward V. ; Jiang, Huiping ; Gan, Weijin ; Tyson, Clare ; Reid, Malcolm S.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Quebec City, Canada, June 16-21, 2007.
 
189. Innovation Adoption in Substance Abuse Treatment: Exposure, Trialability, and the Clinical Trials Network. doc type
  Ducharme, Lori J. ; Knudsen, Hannah K. ; Roman, Paul M. ; Johnson, J. Aaron
 Journal of Substance Abuse Treatment 2007;32:321-329. [doi: 10.1016/j.jsat.2006.05.021].
 
190. Using Buprenorphine to Facilitate Entry into Residential Therapeutic Community Rehabilitation. doc type
  Collins, Eric D. ; Horton, Terry ; Reinke, Katherine ; Amass, Leslie ; Nunes, Edward V.
 Journal of Substance Abuse Treatment 2007;32(2):167-175. [doi: 10.1016/j.jsat.2006.03.018].
 
191. Using Buprenorphine Short-Term Taper to Facilitate Early Treatment Engagement. doc type
  Brigham, Gregory S. ; Amass, Leslie ; Winhusen, Theresa M. ; Harrer, Judith M. ; Pelt, Alvin
 Journal of Substance Abuse Treatment 2007;32(4):349-356. [doi: 10.1016/j.jsat.2006.09.006].
 
192. Starting Treatment with Agonist Replacement Therapy: Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 Bethesda, MD: National Institute on Drug Abuse, 2006.
 
193. Patterns of Organization and Management in Private and Public Substance Abuse Treatment Programs. doc type
  Roman, Paul M. ; Ducharme, Lori J. ; Knudsen, Hannah K.
 Journal of Substance Abuse Treatment 2006;31:235-243. [doi: 10.1016/j.jsat.2006.06.017].
 
194. Smoking Cessation Treatment at Substance Abuse Rehabilitation Programs. doc type
  Reid, Malcolm S. ; Selzer, Jeffrey A. ; Rotrosen, John
 Northeast ATTC Resource Links 2006;5(2):2-5. [Special Issue on Smoking Cessation Treatment and Substance Use Disorders].
 
195. The Clinical Trials Network and Treatment Innovations: Differences in Counselor Attitudes toward Buprenorphine. doc type
  Knudsen, Hannah K. ; Ducharme, Lori J. ; Roman, Paul M. ; Johnson, J. Aaron
 Poster presented at the College on Problems of Drug Dependence annual meeting, June 17-22, 2006.
 
196. Study Design for a Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder in Adolescents with Substance Use Disorders. doc type
  Winhusen, Theresa M.
 Presented at the New Clinical Drug Evaluation Unit (NCDEU) annual meeting, June 12-15, 2006.
 
197. Using Buprenorphine in Opioid Treatment Programs. doc type
  Cohen, Allan J.
 Presented at the American Association for the Treatment of Opioid Dependence (AATOD) annual meeting, Atlanta, GA, April 2006.
 
198. Short Term Opioid Withdrawal Using Buprenorphine (Blending Team Product). doc type
  Freese, Thomas E. ; Brigham, Gregory S. ; Finnerty, Beth ; Gresham-Morrison, Kay ; Harrer, Judith M. ; McCarty, Dennis ; Storti, Susan A.
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2006.
 
199. Challenges in the Adoption of New Pharmacotherapeutics for Addiction to Alcohol and Other Drugs. doc type
  Saxon, Andrew J. ; McCarty, Dennis
 Pharmacology & Therapeutics 2005;108:119-128. [doi: 10.1016/j.pharmthera.2005.06.014].
 
200. Prescription Opioid Addiction Treatment Study: Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
201. A Multi-Center Randomized Trial of Buprenorphine-Naloxone Versus Clonidine for Opioid Detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. doc type doc type
  Ling, Walter ; Amass, Leslie ; Shoptaw, Steven ; Annon, Jeffrey J. ; Hillhouse, Maureen P. ; Babcock, Dean ; Brigham, Gregory S. ; Harrer, Judith M. ; Reid, Malcolm S. ; Muir, Joan A. ; Buchan, Betty J. ; Orr, Deborah ; Woody, George E. ; Krejci, Jonathan ; Ziedonis, Douglas M. ; CTN Buprenorphine Study Team (CTN-0001/0002)
 Addiction 2005; 100(8):1090-1100. [doi: 10.1111/j.1360-0443.2005.01154.x] Correction: Addiction 2006;101(9):1374.
 
202. Buprenorphine Treatment: A Training for Multidisciplinary Addiction Professionals (Blending Team Product) doc type doc type
  Amass, Leslie ; Brigham, Gregory S. ; Clare, Glenda ; Dixon, Gail ; Finnerty, Beth ; Freese, Thomas E. ; Strain, Eric ; Martin, Judith ; McCann, Michael J. ; Obert, Jeanne L. ; Wesson, Donald ; Addiction Technology Transfer Center (ATTC) National Office ; OASIS Clinic
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2005.
 
203. Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience. doc type
  Amass, Leslie ; Ling, Walter ; Freese, Thomas E. ; Reiber, Chris ; Annon, Jeffrey J. ; Cohen, Allan J. ; McCarty, Dennis ; Reid, Malcolm S. ; Brown, Lawrence S. Jr. ; Clark, Cynthia ; Ziedonis, Douglas M. ; Krejci, Jonathan ; Stine, Susan M. ; Winhusen, Theresa M. ; Brigham, Gregory S. ; Babcock, Dean ; Muir, Joan A. ; Buchan, Betty J. ; Horton, Terry
 American Journal on Addictions 2004; 13 (Suppl 1): S42-S66. [doi: 10.1080/10550490490440807].
 
204. Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults : Version III(i), August 14, 2003. doc type
  Woody, George E. ; Forman, Robert F. ; Poole, Sabrina A.
 Presented on August 14, 2003..
 
205. Experimental and Clinical Psychopharmacology: National Institute on Drug Abuse's Clinical Research Agenda. doc type
  Leshner, Alan I.
 Experimental and Clinical Psychopharmacology 2002;10(3):159-161. [doi: 10.1037/1064-1297.10.3.159].
 
206. ADHD in Adolescent Substance Abusers. Parents: Read About a Treatment Study Designed for Your Teenager. doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 Bethesda, MD: National Institute on Drug Abuse, n.d..
 
207. ADHD in Adolescent Substance Abusers. Teenagers 13-18: Read About a Treatment Study Designed Just for You. doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
208. Smoking Cessation Study for Smokers with Attention Deficit Hyperactivity Disorder (ADHD): Should I Participate? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
209. Stop Smoking Study: Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
210. Stop Smoking Study: Now That I Have Joined. . . doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
211. Bup/Nx and Clonidine: A Medication Comparison Study. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
212. Bup/Nx and Clonidine: A Medication Comparison Study. Now That I Have Joined. . . doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
213. Buprenorphine/Naloxone versus Clonidine for Opiate Detoxification : A Medication Comparison Study. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
214. Buprenorphine/Naloxone versus Clonidine for Opiate Detoxification : A Medication Comparison Study. Now That I've Joined. . . doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
215. Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 

New Search